Business Description
Oragenics is a US-based pharmaceutical company focused on developing treatments for brain and infectious diseases, delivered through the nose rather than by injection or pill. Their primary drug candidate, ONP-002, is a lab-made compound designed to pass through the brain's protective barrier, where it works to reduce swelling and inflammation while improving blood flow in patients with mild traumatic brain injuries. Founded in 1996 and based in Lakewood Ranch, Florida, the company continues to advance its pipeline of therapies through ongoing research and development.
